As expected, we found no change in the protein levels of Nck1 or CrkII, a SH2-SH3 domain-containing adaptor protein previously identify as an oncogene [25] and recently reported to regulate sarcoma cell proliferation [26] (Figure 3C). This evidence concerns the gene CRK and sarcoma.